For a more in-depth look at this topic, you may be interested in participating in the second masterclass of our Healthtech Reimbursement Program – Health economics and real-world evidence: payer and purchaser strategies.
More payers and purchasers in the US are interested in understanding the value of adding new products into their therapeutic portfolios. Often that means presenting them with a value proposition solidly grounded in health economics analysis based on real-world data.
This BioBriefing will present the types of health economics analyses to consider when introducing products to US markets as well as how real-world evidence helps develop a convincing value proposition.
Speakers: Dr Melissa Martinson, President, Technomics Research, LLV (USA) & Mr Noel Martinson, President, Acclaim Data Analytics, LLC (USA)
Date: Tuesday 30 July
Time: 3.45 pm registration, presentation & discussion 4.00 pm – 5.00 pm, followed by networking until 6.00 pm
Venue: KPMG, Level 36, Tower Two, 727 Collins Street, Docklands
BioMelbourne Network Members: $65 (incl. GST)
Non Members: $130 (incl. GST)
Note: Participants registered for the second masterclass of the Healthtech Reimbursement program will receive three registrations for this event.
A full refund is given up to 7 days prior to the event. No refunds within 7 days of the event.